SOPH: SEC Form 6-K filed by SOPHiA GENETICS SA
SOPHiA GENETICS files Q3 2026 interim financials and MD&A with the SEC, plus a Nov 3 press release; figures not in filing text.
What this filing says
SOPHiA GENETICS filed a Form 6-K for November 2026 that attaches its unaudited interim financial statements and MD&A for the three and nine months ended September 30, 2026, plus a press release dated November 3, 2026. The filing itself contains only the cover page, signature and exhibit index, so the actual results are in the attached exhibits rather than in this document. For a shareholder, the figures in those exhibits are the substance to review.
Written by Quantisnow AI from this filing. Not financial advice.
Key terms
- Form 6-K:
- A report that foreign private issuers file with the SEC to disclose information such as periodic results and press releases.
- Interim condensed consolidated financial statements:
- Company-wide financial statements covering a period shorter than a full year, prepared without a full audit.
FAQ
What financial information did SOPHiA GENETICS file in this 6-K?
The filing lists three exhibits: unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2026, a management discussion and analysis, and a press release dated November 3, 2026.
Does this filing state SOPHiA GENETICS' results directly?
The main document contains only the cover page, signature and exhibit index, so the specific results are found in the attached exhibits and press release.
Historical context for SOPH
Across the 22 sessions after earlier SOPH headlines, the stock closed higher 12 times and lower 10 times, with a median move of 3.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | SOPH | SPY |
|---|---|---|---|
| Nov 3, 2026 | SOPHiA GENETICS Reports Third Quarter 2026 Results | -2.8% | +0.3% |
| Oct 20, 2026 | SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026 | +6.8% | +0.3% |
| Aug 4, 2026 | SOPHiA GENETICS Reports Second Quarter 2026 Results | +20.2% | +1.8% |
| Jul 21, 2026 | SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 | +2.7% | +0.8% |
| Jul 20, 2026 | H.C. Wainwright initiated coverage on SOPHiA GENETICS SA with a new price target | +7.8% | -0.2% |
| Jun 22, 2026 | SOPHiA GENETICS Publishes Results of the 2026 Annual General Meetingand 1 other headline that session | -2.2% | -0.3% |
- Market cap
- 30-day
- Sector
- Technology
- Industry
- EDP Services
- Listed since
- 2021
Follow SOPH and get a push notification the moment its next story breaks.